Although the presence of pancreatic adenoma or islet-cell carcinoma has been considered to be one facet of the Zollinger—Ellison syndrome, it is not proved that pancreatic abnormality is an ...

Sana Biotechnology said a type 1 diabetes (T1D) patient received an allogeneic primary islet cell transplantation ... hormone receptor-positive breast cancer, said Bayer. North Dakota became ...

A syndrome characterized by severe peptic ulcer disease, gastric acid hypersecretion, and non-beta islet cell tumors of the pancreas was first described by Zollinger and Ellison in 1955.

Often, hyperechoic metastases correspond to hypervascular lesions, including metastases from renal cell carcinoma, breast carcinoma, and islet cell tumors (Fig. 6). Hypoechoic masses tend to be ...

The Seattle-based biotech is evaluating UP421, a donor-derived allogeneic primary islet cell therapy, as a type 1 diabetes treatment that doesn’t require the use of any immunosuppression.

The clinical data are highly promising for patients and provide the first evidence in humans for overcoming allogeneic and autoimmune rejection with pancreatic islet cell transplantation in type 1 ...